A phase 1, single-center, randomized, vehicle-controlled, openlabel clinical trial to evaluate the vasoconstriction properties of topical clascoterone (cortexolone 17a-propionate) cream 1% and clascoterone solution 5% in a vasoconstrictor assay compared to three other corticosteroids in subjects with healthy skin - CB-03-01/39
Latest Information Update: 09 Nov 2026
At a glance
- Drugs Clascoterone (Primary)
- Indications Acne vulgaris; Alopecia
- Focus Therapeutic Use
- Sponsors Cassiopea
Most Recent Events
- 01 Sep 2025 New trial record